255 related articles for article (PubMed ID: 15868449)
1. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
Chen YC; Su HJ; Guo YL; Houseman EA; Christiani DC
Cancer Causes Control; 2005 Mar; 16(2):75-81. PubMed ID: 15868449
[TBL] [Abstract][Full Text] [Related]
2. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
[TBL] [Abstract][Full Text] [Related]
3. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
Tseng CH; Huang YK; Huang YL; Chung CJ; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2005 Aug; 206(3):299-308. PubMed ID: 16039941
[TBL] [Abstract][Full Text] [Related]
4. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
[TBL] [Abstract][Full Text] [Related]
5. Arsenic methylation and bladder cancer risk in Taiwan.
Chen YC; Su HJ; Guo YL; Hsueh YM; Smith TJ; Ryan LM; Lee MS; Christiani DC
Cancer Causes Control; 2003 May; 14(4):303-10. PubMed ID: 12846360
[TBL] [Abstract][Full Text] [Related]
6. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
7. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
8. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer.
Hsueh YM; Chiou HY; Huang YL; Wu WL; Huang CC; Yang MH; Lue LC; Chen GS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):589-96. PubMed ID: 9264271
[TBL] [Abstract][Full Text] [Related]
9. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan.
Huang YK; Tseng CH; Huang YL; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):135-42. PubMed ID: 17173945
[TBL] [Abstract][Full Text] [Related]
10. Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2008; 80(4):405-12. PubMed ID: 18587252
[TBL] [Abstract][Full Text] [Related]
11. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
[TBL] [Abstract][Full Text] [Related]
12. Arsenic methylation capacity and skin cancer.
Yu RC; Hsu KH; Chen CJ; Froines JR
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1259-62. PubMed ID: 11097236
[TBL] [Abstract][Full Text] [Related]
13. [Effects of arsenic exposure through drinking water on methylation in persons].
Li X; Hou P; Sun G
Wei Sheng Yan Jiu; 2008 Nov; 37(6):657-9. PubMed ID: 19238996
[TBL] [Abstract][Full Text] [Related]
14. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
[TBL] [Abstract][Full Text] [Related]
15. Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility.
Huang YK; Pu YS; Chung CJ; Shiue HS; Yang MH; Chen CJ; Hsueh YM
Food Chem Toxicol; 2008 Mar; 46(3):929-38. PubMed ID: 18054417
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS
J Urol; 2009 Feb; 181(2):547-52; discussion 553. PubMed ID: 19084863
[TBL] [Abstract][Full Text] [Related]
17. Arsenic methylation capacity is associated with breast cancer in northern Mexico.
López-Carrillo L; Hernández-Ramírez RU; Gandolfi AJ; Ornelas-Aguirre JM; Torres-Sánchez L; Cebrian ME
Toxicol Appl Pharmacol; 2014 Oct; 280(1):53-9. PubMed ID: 25062773
[TBL] [Abstract][Full Text] [Related]
18. Associations among genetic susceptibility, DNA damage, and pregnancy outcomes of expectant mothers exposed to environmental tobacco smoke.
Wu FY; Wu HD; Yang HL; Kuo HW; Ying JC; Lin CJ; Yang CC; Lin LY; Chiu TH; Lai JS
Sci Total Environ; 2007 Nov; 386(1-3):124-33. PubMed ID: 17610937
[TBL] [Abstract][Full Text] [Related]
19. Carcinogen exposure and epigenetic silencing in bladder cancer.
Marsit CJ; Karagas MR; Schned A; Kelsey KT
Ann N Y Acad Sci; 2006 Sep; 1076():810-21. PubMed ID: 17119258
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]